Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Synthesis of novel isoflavene-propranolol hybrids as anti-tumor agents.

Yee EM, Pasquier E, Iskander G, Wood K, Black DS, Kumar N.

Bioorg Med Chem. 2013 Apr 1;21(7):1652-60. doi: 10.1016/j.bmc.2013.01.059.

PMID:
23462711
2.

Synthesis, biological evaluation and structure-activity relationship studies of isoflavene based Mannich bases with potent anti-cancer activity.

Chen Y, Cass SL, Kutty SK, Yee EM, Chan DS, Gardner CR, Vittorio O, Pasquier E, Black DS, Kumar N.

Bioorg Med Chem Lett. 2015 Nov 15;25(22):5377-83. doi: 10.1016/j.bmcl.2015.09.027.

PMID:
26432036
3.

Synthesis, structure-activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents.

Wang G, Wang F, Cao D, Liu Y, Zhang R, Ye H, Li X, He L, Yang Z, Ma L, Peng A, Xiang M, Wei Y, Chen L.

Bioorg Med Chem Lett. 2014 Jul 15;24(14):3158-63. doi: 10.1016/j.bmcl.2014.04.121.

PMID:
24863745
4.

Synthesis, anti-cancer and anti-inflammatory activity of novel 2-substituted isoflavenes.

Eiffe E, Pasquier E, Kavallaris M, Herbert C, StC Black D, Kumar N.

Bioorg Med Chem. 2014 Oct 1;22(19):5182-93. doi: 10.1016/j.bmc.2014.08.010.

PMID:
25189689
5.

Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment.

Pasquier E, Ciccolini J, Carre M, Giacometti S, Fanciullino R, Pouchy C, Montero MP, Serdjebi C, Kavallaris M, André N.

Oncotarget. 2011 Oct;2(10):797-809.

6.

Synthesis of retinoid enhancers based on 2-aminobenzothiazoles for anti-cancer therapy.

Gardner CR, Cheung BB, Koach J, Black DS, Marshall GM, Kumar N.

Bioorg Med Chem. 2012 Dec 1;20(23):6877-84. doi: 10.1016/j.bmc.2012.09.035.

PMID:
23088909
7.

Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity.

Kolundžija B, Marković V, Stanojković T, Joksović L, Matić I, Todorović N, Nikolić M, Joksović MD.

Bioorg Med Chem Lett. 2014 Jan 1;24(1):65-71. doi: 10.1016/j.bmcl.2013.11.075.

PMID:
24332490
8.

Synthesis and anti-tumor activities of novel oxazinyl isoflavonoids.

Wang D, Hou L, Wu L, Yu X.

Chem Pharm Bull (Tokyo). 2012;60(4):513-20.

9.

Novel pyrazole and indazole derivatives: synthesis and evaluation of their anti-proliferative and anti-angiogenic activities.

Tzanetou E, Liekens S, Kasiotis KM, Fokialakis N, Haroutounian SA.

Arch Pharm (Weinheim). 2012 Oct;345(10):804-11. doi: 10.1002/ardp.201200057.

PMID:
22707414
10.

Design, synthesis, and biological evaluation of the analogues of glaziovianin A, a potent antitumor isoflavone.

Hayakawa I, Ikedo A, Chinen T, Usui T, Kigoshi H.

Bioorg Med Chem. 2012 Oct 1;20(19):5745-56. doi: 10.1016/j.bmc.2012.08.005.

PMID:
22921744
11.

2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique.

Foster PA, Ho YT, Newman SP, Kasprzyk PG, Leese MP, Potter BV, Reed MJ, Purohit A.

Breast Cancer Res Treat. 2008 Sep;111(2):251-60.

PMID:
17957467
12.

Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.

Abadi AH, Abou-Seri SM, Abdel-Rahman DE, Klein C, Lozach O, Meijer L.

Eur J Med Chem. 2006 Mar;41(3):296-305.

PMID:
16494969
13.

Soy Isoflavones and Breast Cancer Cell Lines: Molecular Mechanisms and Future Perspectives.

Uifălean A, Schneider S, Ionescu C, Lalk M, Iuga CA.

Molecules. 2015 Dec 22;21(1):E13. doi: 10.3390/molecules21010013. Review.

14.

Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.

Qamar S, Carrasquer CA, Cunningham SL, Cunningham AR.

Anticancer Res. 2011 Oct;31(10):3247-52.

PMID:
21965732
15.

Synthesis and biological evaluation of scopoletin derivatives.

Cai X, Yang J, Zhou J, Lu W, Hu C, Gu Z, Huo J, Wang X, Cao P.

Bioorg Med Chem. 2013 Jan 1;21(1):84-92. doi: 10.1016/j.bmc.2012.10.059.

PMID:
23218780
16.

Design, synthesis, and antiangiogenic effects of a series of potent novel fumagillin analogues.

Lee HW, Cho CS, Kang SK, Yoo YS, Shin JS, Ahn SK.

Chem Pharm Bull (Tokyo). 2007 Jul;55(7):1024-9.

17.

Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro.

Fernand VE, Losso JN, Truax RE, Villar EE, Bwambok DK, Fakayode SO, Lowry M, Warner IM.

Chem Biol Interact. 2011 Jul 15;192(3):220-32. doi: 10.1016/j.cbi.2011.03.013.

PMID:
21457705
18.

Synthesis and cytotoxic evaluation of novel symmetrical taspine derivatives as anticancer agents.

Zhang J, Zhang Y, Pan X, Wang S, He L.

Med Chem. 2011 Jul;7(4):286-94.

PMID:
21568882
19.

Anti-metastatic and anti-angiogenic properties of potential new anti-cancer drugs based on metal complexes of selenosemicarbazones.

Zec M, Srdic-Rajic T, Konic-Ristic A, Todorovic T, Andjelkovic K, Filipovic-Ljeskovic I, Radulovic S.

Anticancer Agents Med Chem. 2012 Nov;12(9):1071-80.

PMID:
22583413
20.

In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.

Chintalapati M, Truax R, Stout R, Portier R, Losso JN.

J Agric Food Chem. 2009 Jun 24;57(12):5201-10. doi: 10.1021/jf803818y.

PMID:
19476359

Supplemental Content

Support Center